Windtree Therapeutics, a biotech firm that recently announced a $700 million BNB treasury strategy, has been delisted from Nasdaq for failing to meet a listing requirement. The BNB Inspired Rally and Subsequent Plunge Biotech company Windtree Therapeutics, which announced a massive $700 million BNB treasury move, has had its stock delisted from Nasdaq for failing […]
Source: https://news.bitcoin.com/700m-bnb-move-fails-to-save-windtree-from-nasdaq-delisting/
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
[email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.